Filtered By:
Infectious Disease: Herpes

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 364 results found since Jan 2013.

P550 differences in admission complete blood count parameters in eczema herpeticum in children
In this study, we investigated whether complete blood count (CBC) can distinguish EH from AD patients with bacterial infections or exacerbation.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2020 Category: Allergy & Immunology Authors: G. Chan, P. Ong Tags: Skin Disorders Source Type: research

Asthma increases the risk of herpes zoster: a nested case –control study using a national sample cohort
This study aimed to complement previous studies on the risk of herpes zoster in the asthmatic adult population.
Source: Allergy, Asthma and Clinical Immunology - June 23, 2020 Category: Allergy & Immunology Authors: So Young Kim, Dong Jun Oh and Hyo Geun Choi Tags: Research Source Type: research

Herpes Zoster Infection With MS Treatment Higher in Women? Herpes Zoster Infection With MS Treatment Higher in Women?
A review of FDA reports also shows notably higher rates of shingles in women among younger patients taking disease-modifying therapies for multiple sclerosis.Medscape Medical News
Source: Medscape Allergy Headlines - June 4, 2020 Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news

What Are Potential Complications of Tattooing?
Discussion “Tattooing of skin via deposition of pigment particles and ink ingredients in the dermis changes normal skin into abnormal skin. Fortunately, this often causes no harm and no disease, although with important exceptions.” Tattoos can be inadvertent from road dirt, gunpowder, pencil graphite etc., but most are desired. Tattoos are common in many cultures and over time..They have been increasing in popularity in the United States over the past few years particularly with a younger, wider and more diverse population. Newsweek reported an 18-country study in 2018 which showed 46% of Americans have a tat...
Source: PediatricEducation.org - May 18, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

From the Pages of Allergy Watch
For this month ’s issue of Annals, which focuses on vaccines, I’ve selected 3 article summaries from recent Allergy Watch that reviewed studies on various aspects of vaccines. The first reports data from the pivotal study showing the improved efficacy of the new recombinant subunit herpes zoster vaccine. The n ext review describes a report of a unique vaccine for cats that induces IgG blocking antibodies for Fel d 1. The last review shows discrepant results of pneumococcal titers from different labs.
Source: Annals of Allergy, Asthma and Immunology - April 23, 2020 Category: Allergy & Immunology Authors: David A. Khan, Gerald B. Lee, Stanley M. Fineman Tags: Special Series Source Type: research

From the pages of AllergyWatch
For this month's issue of Annals, which focuses on vaccines, there are 3 article summaries from recent AllergyWatch columns that reviewed studies on various aspects of vaccines. The first reports data from a pivotal study on the improved efficacy of the new recombinant subunit herpes zoster vaccine. The second review describes a report of a unique vaccine for cats that induces immunoglobulin G –blocking antibodies for Fel d 1. The third review reports discrepant results of pneumococcal titers from different laboratories.
Source: Annals of Allergy, Asthma and Immunology - April 23, 2020 Category: Allergy & Immunology Authors: David A. Khan, Gerald B. Lee, Stanley M. Fineman Tags: Special Series Source Type: research

Live Herpes Zoster Vaccine Fails to Provide Long-Term Protection in RA Patients on Tofacitinib Live Herpes Zoster Vaccine Fails to Provide Long-Term Protection in RA Patients on Tofacitinib
The live herpes zoster vaccine does not provide reliable long-term protection in rheumatoid arthritis (RA) patients taking tofacitinib, a recent study suggests.Reuters Health Information
Source: Medscape Allergy Headlines - April 20, 2020 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Whole Genome Sequencing Analyses Identify SIDT2 Loss-of-function Mutations In Patients with Eczema Herpeticum
This study aimed to identify rare variants that are associated with AD patients with a history of recurrent EH (ADEH+).
Source: Journal of Allergy and Clinical Immunology - January 31, 2020 Category: Allergy & Immunology Authors: Lianghua Bin, Claire Malley, Patricia Taylor, Meher Preethi Boorgula, Sameer Chavan, Malaika Mathias, Nicholas Rafaels, Ingo Ruczinski, Brittany Richers, Kathleen Barnes, Donald Leung, Rasika Mathias Source Type: research

Eczema Herpeticum: Clinical and Pathophysiological Aspects
AbstractAtopic dermatitis (AD) is the most common chronic inflammatory skin disease in the world. AD is a complex pathology mainly characterized by an impaired skin barrier, immune response dysfunction, and unbalanced skin microbiota. Moreover, AD patients exhibit an increased risk of developing bacterial and viral infections. One of the most current, and potentially life-threatening, viral infection is caused by herpes simplex virus (HSV), which occurs in about 3% of AD patients under the name of eczema herpeticum (EH). Following a first part dedicated to the clinical features, virological diagnosis, and current treatment...
Source: Clinical Reviews in Allergy and Immunology - December 12, 2019 Category: Allergy & Immunology Source Type: research

M056 hsv transverse myelitis in a patient on mepolizumab
Mepolizumab is a monoclonal antibody that inhibits IL-5 indicated as a maintenance treatment for severe eosinophilic asthma. Reactivation of the herpes zoster virus is a known adverse reaction of the drug. Here we present a patient who developed HSV transverse myelitis secondary to his mepolizumab treatment for severe asthma.
Source: Annals of Allergy, Asthma and Immunology - October 31, 2019 Category: Allergy & Immunology Authors: F. Osman, R. Dass, K. Dass Source Type: research

P235 treatment patterns of influenza and zoster vaccinations in patients prescribed mepolizumab
This study examines the prevalence and patterns of influenza and herpes zoster vaccination among patients treated with mepolizumab in the real-world.
Source: Annals of Allergy, Asthma and Immunology - October 31, 2019 Category: Allergy & Immunology Authors: J. Llanos, J. Mao, M. Bogart, J. Silver, C. Blauer-Peterson, E. Hulbert, B. Hahn Source Type: research

M256 nk cell dysfunction presenting as recurrent atypical kawasaki disease
The patient presented twice with atypical Kawasaki disease (KD) with testing positive for adenovirus, Epstein-Barr virus (EBV) on first presentation with significant neutropenia. Second presentation also had significant neutropenia and testing positive for herpes simplex virus (HSV) with viremia triggering concern for immunodeficiency. Work-up revealed reduced natural killer (NK) cell function.
Source: Annals of Allergy, Asthma and Immunology - October 31, 2019 Category: Allergy & Immunology Authors: L. Kaminsky, A. Horwitz, K. Diehl Source Type: research

Shingrix for Herpes Zoster: A Review Shingrix for Herpes Zoster: A Review
This brief primer reviews the pathophysiology of herpes zoster, and summarizes the results of the clinical trials of Shingrex, the newly approved recombinant vaccine for HZ prevention.Skin Therapy Letter
Source: Medscape Allergy Headlines - October 14, 2019 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news

Herpes Zoster after Recombinant Zoster Vaccine: A First Case Report
Publication date: Available online 2 August 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Laurie A. Housel, Bruce M. McClenathan
Source: The Journal of Allergy and Clinical Immunology: In Practice - August 2, 2019 Category: Allergy & Immunology Source Type: research

Use of Topical Steroids in Conjunctivitis: A Review of the Evidence
Conclusions: Corticosteroids, in combination with anti-infectives, could be a promising treatment option for acute conjunctivitis subject to development of further evidence on their effectiveness and safety in conjunctivitis treatment.
Source: Cornea - July 9, 2019 Category: Opthalmology Tags: Review Source Type: research